Market Closed -
Other stock markets
|
Pre-market 14:05:17 | |||
430.09 USD | +4.41% | 429.04 | -0.25% |
Fiscal Period: February | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 7.4B | 6.15B | 8.63B | 10.21B | 11.21B | |||||
Total Revenues | 7.4B | 6.15B | 8.63B | 10.21B | 11.21B | |||||
Cost of Goods Sold, Total | 4.4B | 3.82B | 4.87B | 5.76B | 6.39B | |||||
Gross Profit | 3B | 2.33B | 3.76B | 4.45B | 4.81B | |||||
Selling General & Admin Expenses, Total | 2.08B | 2.02B | 2.45B | 2.8B | 3.13B | |||||
Pre-Opening Costs | 19.25M | 15M | 9.52M | 10.6M | 8.51M | |||||
Other Operating Expenses, Total | 2.1B | 2.04B | 2.46B | 2.81B | 3.14B | |||||
Operating Income | 901M | 299M | 1.29B | 1.64B | 1.68B | |||||
Interest Expense, Total | - | -5.74M | -1.66M | - | - | |||||
Interest And Investment Income | 5.06M | - | - | 4.93M | 17.62M | |||||
Net Interest Expenses | 5.06M | -5.74M | -1.66M | 4.93M | 17.62M | |||||
EBT, Excl. Unusual Items | 906M | 293M | 1.29B | 1.64B | 1.7B | |||||
Restructuring Charges | - | -72.37M | - | - | - | |||||
Asset Writedown | - | -41.95M | - | - | - | |||||
Other Unusual Items | - | 52.4M | 4.02M | - | - | |||||
EBT, Incl. Unusual Items | 906M | 231M | 1.3B | 1.64B | 1.7B | |||||
Income Tax Expense | 200M | 55.25M | 310M | 401M | 405M | |||||
Earnings From Continuing Operations | 706M | 176M | 986M | 1.24B | 1.29B | |||||
Net Income to Company | 706M | 176M | 986M | 1.24B | 1.29B | |||||
Net Income - (IS) | 706M | 176M | 986M | 1.24B | 1.29B | |||||
Net Income to Common Incl Extra Items | 706M | 176M | 986M | 1.24B | 1.29B | |||||
Net Income to Common Excl. Extra Items | 706M | 176M | 986M | 1.24B | 1.29B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 12.21 | 3.12 | 18.09 | 24.17 | 26.18 | |||||
Basic EPS - Continuing Operations | 12.21 | 3.12 | 18.09 | 24.17 | 26.18 | |||||
Basic Weighted Average Shares Outstanding | 57.84M | 56.35M | 54.48M | 51.4M | 49.3M | |||||
Net EPS - Diluted | 12.15 | 3.11 | 17.98 | 24.01 | 26.03 | |||||
Diluted EPS - Continuing Operations | 12.15 | 3.11 | 17.98 | 24.01 | 26.03 | |||||
Diluted Weighted Average Shares Outstanding | 58.1M | 56.56M | 54.84M | 51.74M | 49.6M | |||||
Normalized Basic EPS | 9.79 | 3.25 | 14.82 | 19.98 | 21.49 | |||||
Normalized Diluted EPS | 9.75 | 3.24 | 14.72 | 19.85 | 21.37 | |||||
American Depositary Receipts Ratio (ADR) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.2B | 596M | 1.56B | 1.88B | 1.92B | |||||
EBITA | 901M | 299M | 1.29B | 1.64B | 1.68B | |||||
EBIT | 901M | 299M | 1.29B | 1.64B | 1.68B | |||||
EBITDAR | 1.51B | 981M | 1.95B | 2.28B | 2.35B | |||||
Effective Tax Rate - (Ratio) | 22.09 | 23.91 | 23.92 | 24.41 | 23.86 | |||||
Current Domestic Taxes | 195M | 79.26M | 336M | 385M | 374M | |||||
Total Current Taxes | 195M | 79.26M | 336M | 385M | 374M | |||||
Deferred Domestic Taxes | 5.5M | -24.01M | -25.67M | 15.65M | 30.58M | |||||
Total Deferred Taxes | 5.5M | -24.01M | -25.67M | 15.65M | 30.58M | |||||
Normalized Net Income | 566M | 183M | 807M | 1.03B | 1.06B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 318M | 282M | 388M | 375M | 423M | |||||
Selling and Marketing Expenses | - | - | - | 375M | 423M | |||||
Research And Development Expense From Footnotes | 926K | 926K | 926K | 1.01M | 889K | |||||
Net Rental Expense, Total | 318M | 385M | 389M | 405M | 433M | |||||
Imputed Operating Lease Interest Expense | - | 9.21M | 2.76M | - | - | |||||
Imputed Operating Lease Depreciation | - | 376M | 386M | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 25.64M | 27.58M | 47.26M | 43.04M | 48.25M | |||||
Total Stock-Based Compensation | 25.64M | 27.58M | 47.26M | 43.04M | 48.25M |